Evidence map›Paper›PMID 38084353›Full record

ArticleClinical case reports2023

Bilateral endogenous

Shuang Wu, Cunbo Wang, Yanbing Zhang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Bilateral endogenousClinical case reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shuang WuDepartment of Ophthalmology Changyi People's Hospital Weifang Shandong China.ORCID https://orcid.org/0000-0001-7236-6819
Cunbo WangDepartment of Ophthalmology Changyi People's Hospital Weifang Shandong China.
Yanbing ZhangDepartment of Ophthalmology Changyi People's Hospital Weifang Shandong China.
Weifang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Endogenous fungal endophthalmitis tends to occur in immunocompromised patients, including COVID-19 infection. For high-risk populations, timely tissue biopsy, fungal culture, and susceptibility testing can facilitate early diagnosis and treatment, thereby improving the prognosis. Abstract: While endogenous fungal endophthalmitis is a rare condition, its incidence has recently been on the rise. A 48-year-old male presented with complaints of acute visual loss in his right eye for 2 weeks. He had a history of COVID-19 infection, confirmed by a positive nucleic acid test, and was treated with intravenous antibiotics and glucocorticoids a week before the episode. A comprehensive eye examination revealed significant inflammatory cells floating in the anterior chamber and considerable cloudiness in the vitreous of the right eye, while few vitreous cells were visualized in the left eye. After pars plana vitrectomy (PPV) was performed in the right eye, a vitreous biopsy revealed an intravitreal infection of

Indexed as

Candida albicansCOVID‐19endogenous fungal endophthalmitisfluconazole

Identifiers

PMID38084353
PMCPMC10710527
OpenAlexW4389514875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.